Ergoteles LLC Axcella Health Inc. Transaction History

Ergoteles LLC

  • $68.2 Billion
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$2.06 - $3.61 $95,701 - $167,709
-46,457 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$2.98 - $4.31 $52,322 - $75,674
-17,558 Reduced 27.43%
46,457 $138,000
Q2 2021

Aug 12, 2021
BUY
$3.08 - $5.13 $197,166 - $328,396
64,015 New
64,015 $257,000

Others Institutions Holding AXLA

# of Institutions
2
Shares Held
61.6K
Call Options Held
0
Put Options Held
0
View Full List

About Axcella Health Inc.

AXLA Quotes by TradingView
  • Ticker AXLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,500,896
  • Description
  • Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...
More about AXLA
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email